Workflow
Neuromodulation treatment of epilepsy
icon
Search documents
LivaNova PLC (LIVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Seeking Alphaยท 2025-09-10 20:00
Company Overview - LivaNova demonstrates strong and durable growth in its core businesses, which include neuromodulation for epilepsy treatment and cardiopulmonary solutions [1][2] - The company has a diversified portfolio and holds leadership positions in its respective markets [1][2] Market Expansion Strategy - LivaNova aims to expand into markets with significant unmet patient needs, focusing on high-growth areas where the company has competitive advantages [2]